Soluble CD40 ligand, a mediator of sepsis or of transfusion-related adverse effects?

scientific article published on 31 May 2011

Soluble CD40 ligand, a mediator of sepsis or of transfusion-related adverse effects? is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1023147360
P356DOI10.1186/CC10237
P932PMC publication ID3218990
P698PubMed publication ID21639957
P5875ResearchGate publication ID51190270

P50authorPieter Roel TuinmanQ42314955
Nicole P JuffermansQ88062370
P2860cites workThe platelet as an immune cell-CD40 ligand and transfusion immunomodulationQ33937074
Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis.Q35559467
Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injuryQ35849153
Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literatureQ37234940
Platelet-derived CD40L (CD154) mediates neutrophil upregulation of Mac-1 and recruitment in septic lung injuryQ45056628
Transfusion-related risk of secondary bacterial infections in sepsis patients: a retrospective cohort study.Q50550381
P433issue3
P921main subjectsepsisQ183134
P304page(s)429; author reply 429
P577publication date2011-05-31
P1433published inCritical CareQ5186602
P1476titleSoluble CD40 ligand, a mediator of sepsis or of transfusion-related adverse effects?
P478volume15

Reverse relations

cites work (P2860)
Q92995659Evidence of CD40L/CD40 pathway involvement in experimental transfusion-related acute lung injury
Q37233599New strategy for sepsis: Targeting a key role of platelet-neutrophil interaction